Product NDC: | 0409-7419 |
Proprietary Name: | LMD in Sodium Chloride |
Non Proprietary Name: | DEXTRAN 40 |
Active Ingredient(s): | 10 g/100mL & nbsp; DEXTRAN 40 |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-7419 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA720562 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110308 |
Package NDC: | 0409-7419-03 |
Package Description: | 12 POUCH in 1 CASE (0409-7419-03) > 1 BAG in 1 POUCH > 500 mL in 1 BAG |
NDC Code | 0409-7419-03 |
Proprietary Name | LMD in Sodium Chloride |
Package Description | 12 POUCH in 1 CASE (0409-7419-03) > 1 BAG in 1 POUCH > 500 mL in 1 BAG |
Product NDC | 0409-7419 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | DEXTRAN 40 |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20110308 |
Marketing Category Name | ANDA |
Labeler Name | Hospira, Inc. |
Substance Name | DEXTRAN 40 |
Strength Number | 10 |
Strength Unit | g/100mL |
Pharmaceutical Classes | Plasma Volume Expander [EPC],Increased Intravascular Volume [PE],Osmotic Activity [MoA] |